Cargando…
Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients
METHODS: A total of 111 patients in total from different disease phases were recruited, including 21 in immune-tolerant (IT) phase, 49 in immune-clearance (IC) phases, 29 in immune-control or low replicative (LR) phase, and 12 in reactivation phases. Serum HBV RNA, anti-HBc, HBcrAg, and intrahepatic...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303147/ https://www.ncbi.nlm.nih.gov/pubmed/35872701 http://dx.doi.org/10.1155/2022/4133283 |
_version_ | 1784751790956216320 |
---|---|
author | Liao, Hao Li, Le Zheng, Wei V. Zou, Jun Yu, Guangxin Si, Lanlan Ge, Feilin Zhou, Tao Ji, Dong Chen, Xiangmei Xu, Dongping Cheng, Guanxun Liu, Yan Chen, Junhui |
author_facet | Liao, Hao Li, Le Zheng, Wei V. Zou, Jun Yu, Guangxin Si, Lanlan Ge, Feilin Zhou, Tao Ji, Dong Chen, Xiangmei Xu, Dongping Cheng, Guanxun Liu, Yan Chen, Junhui |
author_sort | Liao, Hao |
collection | PubMed |
description | METHODS: A total of 111 patients in total from different disease phases were recruited, including 21 in immune-tolerant (IT) phase, 49 in immune-clearance (IC) phases, 29 in immune-control or low replicative (LR) phase, and 12 in reactivation phases. Serum HBV RNA, anti-HBc, HBcrAg, and intrahepatic covalently closed circular DNA (cccDNA) were quantified and each of these indicator's correlation with liver inflammation was analyzed. RESULTS: HBeAg-positive individuals had significant higher serum levels of HBV RNA and HBcrAg than those who were HBeAg negative, similar to that of serum HBV DNA. Comparatively, HBV RNA (r =0.79, P < 0.01) and HBcrAg (r =0.78, P < 0.01) had almost same higher overall correlation with the cccDNA, as that of HBV DNA (r =0.81, P < 0.01). Serum anti-HBc level (r = -0.52, P < 0.05) is negatively correlated with cccDNA level at IT phase rather than the other three phases. When set the cutoff value at 4.00 log(10) IU/mL, serum anti-HBc showed potential to indicate liver inflammation, with AUC as 0.79 and the specificities as 78.85% for HBeAg positive, and with AUC as 0.72 and the specificities as 62.16% for HBeAg-negative patients, respectively. CONCLUSIONS: In treatment-naïve patients, levels of serological markers HBV RNA and HBcrAg could mirror intrahepatic cccDNA level, but were not superior to HBV DNA level. Serum anti-HBc level had certain potential to be used as a predicting marker for liver inflammation. |
format | Online Article Text |
id | pubmed-9303147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-93031472022-07-22 Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients Liao, Hao Li, Le Zheng, Wei V. Zou, Jun Yu, Guangxin Si, Lanlan Ge, Feilin Zhou, Tao Ji, Dong Chen, Xiangmei Xu, Dongping Cheng, Guanxun Liu, Yan Chen, Junhui Dis Markers Research Article METHODS: A total of 111 patients in total from different disease phases were recruited, including 21 in immune-tolerant (IT) phase, 49 in immune-clearance (IC) phases, 29 in immune-control or low replicative (LR) phase, and 12 in reactivation phases. Serum HBV RNA, anti-HBc, HBcrAg, and intrahepatic covalently closed circular DNA (cccDNA) were quantified and each of these indicator's correlation with liver inflammation was analyzed. RESULTS: HBeAg-positive individuals had significant higher serum levels of HBV RNA and HBcrAg than those who were HBeAg negative, similar to that of serum HBV DNA. Comparatively, HBV RNA (r =0.79, P < 0.01) and HBcrAg (r =0.78, P < 0.01) had almost same higher overall correlation with the cccDNA, as that of HBV DNA (r =0.81, P < 0.01). Serum anti-HBc level (r = -0.52, P < 0.05) is negatively correlated with cccDNA level at IT phase rather than the other three phases. When set the cutoff value at 4.00 log(10) IU/mL, serum anti-HBc showed potential to indicate liver inflammation, with AUC as 0.79 and the specificities as 78.85% for HBeAg positive, and with AUC as 0.72 and the specificities as 62.16% for HBeAg-negative patients, respectively. CONCLUSIONS: In treatment-naïve patients, levels of serological markers HBV RNA and HBcrAg could mirror intrahepatic cccDNA level, but were not superior to HBV DNA level. Serum anti-HBc level had certain potential to be used as a predicting marker for liver inflammation. Hindawi 2022-07-14 /pmc/articles/PMC9303147/ /pubmed/35872701 http://dx.doi.org/10.1155/2022/4133283 Text en Copyright © 2022 Hao Liao et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Liao, Hao Li, Le Zheng, Wei V. Zou, Jun Yu, Guangxin Si, Lanlan Ge, Feilin Zhou, Tao Ji, Dong Chen, Xiangmei Xu, Dongping Cheng, Guanxun Liu, Yan Chen, Junhui Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients |
title | Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients |
title_full | Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients |
title_fullStr | Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients |
title_full_unstemmed | Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients |
title_short | Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients |
title_sort | characteristics of hbv novel serum markers across distinct phases in treatment-naïve chronic hbv-infected patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303147/ https://www.ncbi.nlm.nih.gov/pubmed/35872701 http://dx.doi.org/10.1155/2022/4133283 |
work_keys_str_mv | AT liaohao characteristicsofhbvnovelserummarkersacrossdistinctphasesintreatmentnaivechronichbvinfectedpatients AT lile characteristicsofhbvnovelserummarkersacrossdistinctphasesintreatmentnaivechronichbvinfectedpatients AT zhengweiv characteristicsofhbvnovelserummarkersacrossdistinctphasesintreatmentnaivechronichbvinfectedpatients AT zoujun characteristicsofhbvnovelserummarkersacrossdistinctphasesintreatmentnaivechronichbvinfectedpatients AT yuguangxin characteristicsofhbvnovelserummarkersacrossdistinctphasesintreatmentnaivechronichbvinfectedpatients AT silanlan characteristicsofhbvnovelserummarkersacrossdistinctphasesintreatmentnaivechronichbvinfectedpatients AT gefeilin characteristicsofhbvnovelserummarkersacrossdistinctphasesintreatmentnaivechronichbvinfectedpatients AT zhoutao characteristicsofhbvnovelserummarkersacrossdistinctphasesintreatmentnaivechronichbvinfectedpatients AT jidong characteristicsofhbvnovelserummarkersacrossdistinctphasesintreatmentnaivechronichbvinfectedpatients AT chenxiangmei characteristicsofhbvnovelserummarkersacrossdistinctphasesintreatmentnaivechronichbvinfectedpatients AT xudongping characteristicsofhbvnovelserummarkersacrossdistinctphasesintreatmentnaivechronichbvinfectedpatients AT chengguanxun characteristicsofhbvnovelserummarkersacrossdistinctphasesintreatmentnaivechronichbvinfectedpatients AT liuyan characteristicsofhbvnovelserummarkersacrossdistinctphasesintreatmentnaivechronichbvinfectedpatients AT chenjunhui characteristicsofhbvnovelserummarkersacrossdistinctphasesintreatmentnaivechronichbvinfectedpatients |